Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Quit Smoking Drugs Global Market Report 2025
Download Free Sample Buy Now
Global Quit Smoking Drugs Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Quit Smoking Drugs Global Market Report 2025

By Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets), By Drug (Varenicline (Chantix), Bupropion (Zyban), Other Drugs), By Distribution (Drug Store, Online Pharmacies, Retail Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Quit Smoking Drugs Market Overview

• Quit Smoking Drugs market size has reached to $39.26 billion in 2024

• Expected to grow to $78.3 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%

• Growth Driver: Rising Addiction Linked To Smoking Fuels Growth In Quit-Smoking Drug Market

• Market Trend: Innovative Product Strategies Drive Growth In The Quit Smoking Drugs Market

• North America was the largest region in 2024.

What Is Covered Under Quit Smoking Drugs Market?

Quit smoking drugs are special drugs that individuals use in quitting smoking and that decrease craving and other nicotine withdrawal symptoms. It is used to deliver nicotine in an alternate form, such as chewing gum or patches, for a brief period, which lessens the withdrawal symptoms from nicotine and the urge to smoke.

The major products of quit-smoking drugs are drug therapy, electronic cigarettes, nicotine inhalers, nicotine replacement therapies, and nicotine sublingual tablets. Drug therapy refers to the administration of drugs to treat or prevent disease. Drugs such as Varenicline (Chantix), Bupropion (Zyban), and others are available in drug stores, online pharmacies, and retail pharmacies.

Quit Smoking Drugs Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Quit Smoking Drugs Market Size 2025 And Growth Rate?

The quit smoking drugs market size has grown rapidly in recent years. It will grow from $39.26 billion in 2024 to $44.23 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to health awareness campaigns, medical advancements, government initiatives, behavioral therapies integration, consumer attitude shifts.

What Is The Quit Smoking Drugs Market Growth Forecast?

The quit smoking drugs market size is expected to see rapid growth in the next few years. It will grow to $78.3 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to research and development investments, growing demand for cessation aids, targeted marketing and awareness campaigns, advancements in pharmacotherapy. Major trends in the forecast period include personalized treatment approaches, increasing health consciousness, digital therapeutics and apps, behavioral therapy integration, targeted marketing and education.

The forecast of 15.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions might hinder U.S. cessation programs by driving up prices of nicotine receptor partial agonists and behavioral therapy adjuncts sourced from the UK and Switzerland, leading to reduced smoking cessation success rates and higher public health costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Quit Smoking Drugs Market Segmented?

1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets

2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs

3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)

2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems

3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers

4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges

5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

What Is Driving The Quit Smoking Drugs Market? Rising Addiction Linked To Smoking Fuels Growth In Quit-Smoking Drug Market

The growing prevalence of smoking addiction is expected to propel the growth of the quit-smoking drug market going forward. Smoking is the practice of inhaling and exhaling burning plant material vapors such as marijuana and hashish, tobacco, and others. Quit smoking drugs are used to reduce the urge to smoke by hampering the craving for tobacco in an individual, where it is used as a prescription medication to control nicotine withdrawal symptoms to aid in quitting smoking effectively. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Also, the total number of cigarettes sold rose by 1.3% from May 2022, reaching 1.4 billion in June 2022.Therefore, the growing prevalence of smoking addiction is driving the growth of the quit-smoking drug market.

What Is Driving The Quit Smoking Drugs Market? Rise Of E-Commerce Is Anticipated To Fuel Quit Smoking Drugs Market

The rise of e-commerce is expected to propel the growth of the quit-smoking drugs market going forward. E-commerce, or electronic commerce, refers to the buying and selling of goods and services over the Internet. Quit smoking drugs are increasingly accessible through e-commerce platforms, providing a convenient and discreet avenue for individuals seeking smoking cessation solutions. For instance, in August 2023, The Census Bureau, a US-based principal agency, estimated that the U.S. retail e-commerce sales for the second quarter of 2023, adjusted for seasonal variation, but not for price changes, was $277.6 billion, an increase of 2.1 percent (±0.9%) from the first quarter of 2023. Therefore, the rise of e-commerce is driving the quit-smoking drugs market.

Who Are The Major Players In The Global Quit Smoking Drugs Market?

Major companies operating in the quit smoking drugs market include 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp.

What Are The Key Trends Of The Global Quit Smoking Drugs Market? Innovative Product Strategies Drive Growth In The Quit Smoking Drugs Market

Product innovations are a key trend in gaining popularity in the quit smoking drugs. Major companies operating in the quit-smoking drug market are focused on innovating products to strengthen their position in the market. For instance, in August 2022, Swedish Match AB, a Sweden-based tobacco company, launched ZYN Tobacco Gold, a tobacco flavored, nicotine pouch in travel retail. Tobacco Gold is available in medium (3 mg) and strong (6 mg) strengths. The pouches' sweet tobacco flavor, which is reminiscent of dried fruit, wood, and caramel, satisfies consumer desires since tobacco has emerged as the most popular flavor to help consumers opt for reduced-risk alternatives that are both tobacco-free and smoke-free. It provides a solution for cigarette smokers who not only want to prevent the consumption of tobacco but also enjoy a nicotine kick in smoke-free environments.

What Are The Key Trends Of The Global Quit Smoking Drugs Market? Medicated Products To Address The Unacceptably High Death Burden

Major companies operating in the quit smoking drugs market are focusing on the development of new formulations and delivery methods, such as generic tablets, to expand market leadership across regions and gain a competitive edge. Generic varenicline tablets are non-branded versions of the medication containing varenicline tartrate, which are bioequivalent to the original branded product and used for smoking cessation therapy. For instance, in January 2024, Lupin Limited, an India-based pharmaceutical company, launched new Varenicline tablets in the United States, available in 0.5 mg and 1 mg strengths. These tablets are the generic versions of Chantix tablets (0.5 mg and 1 mg) from PF Prism C.V. and are used to assist in smoking cessation treatment. As a partial agonist of the nicotinic acetylcholine receptor, varenicline works by stimulating the release of dopamine, which can alleviate withdrawal symptoms and cravings associated with nicotine addiction. This dual mechanism allows it to reduce the pleasurable effects of smoking while providing some stimulation to minimize withdrawal effects.

Need data on a specific region in this market?
Request Regional Data

Quit Smoking Drugs Market Merger And Acquisition: Dr. Reddy's Acquires Haleon's Nicotine Replacement Therapy Business

In September 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, acquired the nicotine replacement therapy business from Haleon plc for $680 million (£500 million). The aim of the acquisition is to strengthen Dr. Reddy's position in the global consumer healthcare market, particularly by enhancing its over-the-counter (OTC) offerings and expanding its presence in key international markets outside the United States. Haleon plc is a UK-based consumer health company that specializes in nicotine addiction drugs.

Regional Analysis For The Global Quit Smoking Drugs Market

North America was the largest region in the quit smoking drugs market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Quit Smoking Drugs Market?

The quit-smoking drugs market consists of sales of AXS-05, cytisincline, nadolol, and liraglutide. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Quit Smoking Drugs Industry?

The quit smoking drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the quit smoking drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Quit Smoking Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $44.23 billion
Revenue Forecast In 2034 $78.3 billion
Growth Rate CAGR of 15.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets
2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs
3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies Subsegments: 1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)
2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems
3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers
4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges
5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Quit Smoking Drugs Market Characteristics

3. Quit Smoking Drugs Market Trends And Strategies

4. Quit Smoking Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Quit Smoking Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Quit Smoking Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Quit Smoking Drugs Market Growth Rate Analysis

5.4. Global Quit Smoking Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Quit Smoking Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Quit Smoking Drugs Total Addressable Market (TAM)

6. Quit Smoking Drugs Market Segmentation

6.1. Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Therapy

E-Cigarettes

Nicotine Inhalers

Nicotine Replacement Therapies

Nicotine Sublingual Tablets

6.2. Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Varenicline (Chantix)

Bupropion (Zyban)

Other Drugs

6.3. Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Store

Online Pharmacies

Retail Pharmacies

6.4. Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bupropion (Zyban)

Varenicline (Chantix)

6.5. Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Disposable E-Cigarettes

Rechargeable E-Cigarettes

Pod Systems

6.6. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prescription Inhalers

Over-The-Counter Inhalers

6.7. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies (NRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nicotine Patches

Nicotine Gum

Nicotine Lozenges

6.8. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fast-Acting Sublingual Tablets

Extended-Release Sublingual Tablets

7. Quit Smoking Drugs Market Regional And Country Analysis

7.1. Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Quit Smoking Drugs Market

8.1. Asia-Pacific Quit Smoking Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Quit Smoking Drugs Market

9.1. China Quit Smoking Drugs Market Overview

9.2. China Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Quit Smoking Drugs Market

10.1. India Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Quit Smoking Drugs Market

11.1. Japan Quit Smoking Drugs Market Overview

11.2. Japan Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Quit Smoking Drugs Market

12.1. Australia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Quit Smoking Drugs Market

13.1. Indonesia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Quit Smoking Drugs Market

14.1. South Korea Quit Smoking Drugs Market Overview

14.2. South Korea Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Quit Smoking Drugs Market

15.1. Western Europe Quit Smoking Drugs Market Overview

15.2. Western Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Quit Smoking Drugs Market

16.1. UK Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Quit Smoking Drugs Market

17.1. Germany Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Quit Smoking Drugs Market

18.1. France Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Quit Smoking Drugs Market

19.1. Italy Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Quit Smoking Drugs Market

20.1. Spain Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Quit Smoking Drugs Market

21.1. Eastern Europe Quit Smoking Drugs Market Overview

21.2. Eastern Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Quit Smoking Drugs Market

22.1. Russia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Quit Smoking Drugs Market

23.1. North America Quit Smoking Drugs Market Overview

23.2. North America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Quit Smoking Drugs Market

24.1. USA Quit Smoking Drugs Market Overview

24.2. USA Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Quit Smoking Drugs Market

25.1. Canada Quit Smoking Drugs Market Overview

25.2. Canada Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Quit Smoking Drugs Market

26.1. South America Quit Smoking Drugs Market Overview

26.2. South America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Quit Smoking Drugs Market

27.1. Brazil Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Quit Smoking Drugs Market

28.1. Middle East Quit Smoking Drugs Market Overview

28.2. Middle East Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Quit Smoking Drugs Market

29.1. Africa Quit Smoking Drugs Market Overview

29.2. Africa Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Quit Smoking Drugs Market Competitive Landscape And Company Profiles

30.1. Quit Smoking Drugs Market Competitive Landscape

30.2. Quit Smoking Drugs Market Company Profiles

30.2.1. 22nd Century Group Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Cipla Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. GSK Plc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

31. Quit Smoking Drugs Market Other Major And Innovative Companies

31.1. NJOY LLC

31.2. Novartis AG

31.3. Perrigo Company Plc

31.4. Pfizer Inc.

31.5. Philip Morris International

31.6. Glenmark Pharmaceuticals Limited

31.7. Zydus Cadila Healthcare Limited

31.8. Rusan Pharma Ltd.

31.9. BioCorRx Inc.

31.10. CV Sciences Inc.

31.11. Ennaid Therapeutics LLC

31.12. Fertin Pharma A/S

31.13. Gilla Inc.

31.14. Hikma Pharmaceuticals PLC

31.15. Innovus Pharmaceuticals Inc.

32. Global Quit Smoking Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quit Smoking Drugs Market

34. Recent Developments In The Quit Smoking Drugs Market

35. Quit Smoking Drugs Market High Potential Countries, Segments and Strategies

35.1 Quit Smoking Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Quit Smoking Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Quit Smoking Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies (NRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: 22nd Century Group Financial Performance
  • Table 80: Cipla Limited Financial Performance
  • Table 81: Dr. Reddy's Laboratories Financial Performance
  • Table 82: GSK Plc. Financial Performance
  • Table 83: Johnson & Johnson Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies (NRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: 22nd Century Group Financial Performance
  • Figure 80: Cipla Limited Financial Performance
  • Figure 81: Dr. Reddy's Laboratories Financial Performance
  • Figure 82: GSK Plc. Financial Performance
  • Figure 83: Johnson & Johnson Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Read More About Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

Read More About Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Quit Smoking Drugs Global Market Report 2025 – By Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets), By Drug (Varenicline (Chantix), Bupropion (Zyban), O...

View Report

Nicotine Addiction Treatment Global Market Report 2025 – By Type (Pharmacological, Therapies, Other Types ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By End-User (Generation Z, Mill...

View Report

Nicotine Addiction Treatment Global Market Report 2025 – By Type (Pharmacological, Therapies, Other Types ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By End-User (Generation Z, Mill...

View Report

E-Cigarettes Global Market Report 2025 – By Product Type (Disposable, Rechargeable, Modular), By Composition Used (Tobacco, Flavors, Nicotine-free), By Distribution Channel (Specialist E-Cig Shops, Online, Supermarkets, ...

View Report

Nicotine Addiction Treatment Global Market Report 2025 – By Type (Pharmacological, Therapies, Other Types ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By End-User (Generation Z, Mill...

View Report

Hot Tobacco Global Market Report 2025 – By Product (Hnb Tobacco Devices, Direct/Indirect Heating Hnb Tobacco, Infused/Hybrid Hnb Tobacco Devices, Hnb Tobacco Consumables, Hnb Tobacco Sticks, Hnb Tobacco Capsules, Cartrid...

View Report

Nicotine Replacement Therapy Global Market Report 2025 – By Product Type (Patch, Gum, Lozenge, Inhaler, Spray, Other Products), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Location (...

View Report

Smokeless Tobacco Global Market Report 2025 – By Type (Chewing Tobacco, Dipping Tobacco, Dissolvable Tobacco, Snuff, Other Types), By Form (Moist, Dry), By Route (Oral, Nasal), By Distribution Channel (Convenience Or Tra...

View Report

Frequently Asked Questions

Quit smoking drugs are special drugs that individuals use in quitting smoking and that decrease craving and other nicotine withdrawal symptoms. It is used to deliver nicotine in an alternate form, such as chewing gum or patches, for a brief period, which lessens the withdrawal symptoms from nicotine and the urge to smoke. For further insights on this market, request a sample here

The market major growth driver - Rising Addiction Linked To Smoking Fuels Growth In Quit-Smoking Drug Market. For further insights on this market, request a sample here

The quit smoking drugs market size has grown rapidly in recent years. It will grow from $39.26 billion in 2024 to $44.23 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to health awareness campaigns, medical advancements, government initiatives, behavioral therapies integration, consumer attitude shifts. The quit smoking drugs market size is expected to see rapid growth in the next few years. It will grow to " $78.3 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to research and development investments, growing demand for cessation aids, targeted marketing and awareness campaigns, advancements in pharmacotherapy. Major trends in the forecast period include personalized treatment approaches, increasing health consciousness, digital therapeutics and apps, behavioral therapy integration, targeted marketing and education. For further insights on this market, request a sample here

The quit smoking drugs market covered in this report is segmented –
1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets
2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs
3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies Subsegments:
1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)
2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems
3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers
4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges
5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets For further insights on this market, request a sample here

North America was the largest region in the quit smoking drugs market in 2024. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the quit smoking drugs market include 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Product Strategies Drive Growth In The Quit Smoking Drugs Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Quit Smoking Drugs Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon